Alpha Tau Medical and Samsung Medical Center Sign MOU for Pancreatic Cancer Clinical Trial

Alpha Tau Medical Ltd. has entered into a Memorandum of Understanding with Samsung Medical Center to explore a clinical trial for pancreatic cancer using its Alpha DaRT technology. This collaboration aims to assess the effectiveness of this radiation therapy for patients in Korea, representing a strategic move to broaden the application of its intratumoral alpha-irradiation technology for solid tumors.